Durata Therapeutics, Inc (DRTX)

[koman]

At this point it seems that they are focusing on manufacturing and going solo. This does not mean that there won't be an offer by big pharma later on but I doubt we see such announcement anytime soon. Either scenario of going alone or future sale of co will most likely mean a higher pps so at this level it is a bargain. I would like to see pps of 30 but I can't predict when such target will be met if ever. Everyone will want to look at sales number and product launch expense but that data won't be until next year, so if you want to get the most benefit from this stock you will have to really hold this one til next summer. GL Also, let's hear what management plans to do about future growth etc ie will they buy another product?